Search

Heron Therapeutics Inc

Suletud

SektorTervishoid

0.49 2.08

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

0.44

Max

0.49

Põhinäitajad

By Trading Economics

Sissetulek

-5.2M

-8.1M

Müük

-5.9M

35M

Aktsiakasum

-0.04

Kasumimarginaal

-23.367

Töötajad

128

EBITDA

-6.8M

-7.6M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+316.67% upside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

10. aug 2026

Turustatistika

By TradingEconomics

Turukapital

-143M

87M

Eelmine avamishind

-1.59

Eelmine sulgemishind

0.49

Uudiste sentiment

By Acuity

19%

81%

30 / 340 Pingereas Healthcare

Heron Therapeutics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

28. juuli 2026, 23:56 UTC

News

Coursera Inc announced a $100 million investment in LearnVector, enhancing its AI strategy. Shares are trading higher during after-market hours.

28. juuli 2026, 23:52 UTC

News
Correlated Moves
Social Media

Apple Inc. shares are higher in after-market trading as the company surpasses a $5 trillion market capitalization ahead of its Q3 earnings report.

28. juuli 2026, 23:52 UTC

Social Media
News

Avis Budget Group shares lower in after-market trading following second-quarter results that missed expectations, with EPS of $0.98 against estimates of $1.91.

28. juuli 2026, 23:52 UTC

News
Social Media

Verra Mobility Corp announced a seven-year tolling services contract with Avis Budget Group. Shares rose sharply in after-market trading following the announcement.

28. juuli 2026, 23:52 UTC

Social Media
News

Ford Motor Co reported Q2 earnings, with adjusted EPS of $0.42 and revenue of $48.3 billion. Shares rose significantly in after-market hours.

28. juuli 2026, 23:52 UTC

News
Social Media

PPG Industries shares declined in after-market hours following mixed second-quarter results, with adjusted EPS of $2.23 falling short of estimates.

28. juuli 2026, 23:52 UTC

News
Social Media
Correlated Moves

NVIDIA shares are higher in after-market hours as analysts cite low valuation relative to growth potential, suggesting a strong buying opportunity.

28. juuli 2026, 23:52 UTC

Social Media
News

IONQ Inc has received regulatory approval for its acquisition of SkyWater Technology. Shares are lower in after-market hours despite the positive development.

28. juuli 2026, 23:52 UTC

Correlated Moves
News

FormFactor and Keystone Microtech expand their strategic partnership to enhance manufacturing scalability for advanced probe card solutions. Shares rise in after-market trading.

28. juuli 2026, 23:52 UTC

ETF Constituents
Correlated Moves
News
Social Media

Invesco QQQ Trust Series I is higher in after-market trading, supported by gains from Microsoft, Broadcom, Netflix, Amazon, and AMD amid ongoing market concerns.

28. juuli 2026, 23:52 UTC

Social Media
News

September WTI Crude Oil futures rose above $82.50 after an Iranian missile attack on U.S. forces, boosting United States Oil Fund LP in after-market trading.

28. juuli 2026, 23:52 UTC

News
Correlated Moves
ETF Constituents

Vanguard Information Technology ETF is trading higher in after-market hours, supported by strong performances from top holdings like Microsoft and AMD.

28. juuli 2026, 23:52 UTC

Social Media
Correlated Moves
News

Advanced Micro Devices is higher in after-market hours, supported by GIGABYTE's plans for servers using AMD EPYC processors and positive social media sentiment.

28. juuli 2026, 23:52 UTC

News
Social Media
Correlated Moves

Amazon.com Inc is higher in after-market hours, boosted by positive market sentiment and its exclusive streaming rights for NHL playoff games on Prime Video.

28. juuli 2026, 23:51 UTC

News

Bloom Energy Corp reported second-quarter revenue of $1.07 billion and raised its 2026 revenue guidance, with shares trading higher in after-market hours.

28. juuli 2026, 23:51 UTC

News
Social Media

BofA Securities maintained its Buy rating on Intel Corp with a $160 price target, as shares rise in after-market trading amid positive sentiment and options activity.

28. juuli 2026, 23:51 UTC

News

Herc Holdings Inc reported strong Q2 results and raised full-year guidance, with shares trading higher in after-market hours.

28. juuli 2026, 23:51 UTC

News
Correlated Moves

Concerns over competition from China and AI demand sustainability weigh on semiconductor stocks. Applied Materials shares are near unchanged in after-market hours.

28. juuli 2026, 23:46 UTC

Correlated Moves
News

Matador Resources Co trades higher since Tuesday's close.

28. juuli 2026, 23:42 UTC

Social Media
News

KLA Corp shares declined in after-hours trading despite reporting net income of $1.36 billion, as first-quarter guidance fell short of expectations.

28. juuli 2026, 23:41 UTC

News
Social Media

Microsoft shares rise in after-market trading as investors await earnings report, with revenue expectations at $87.62 billion and EPS estimated at $4.24.

28. juuli 2026, 23:41 UTC

Correlated Moves
News

Joby Aviation shares are lower in after-market trading following the announcement about outstanding warrants expiring in 2026, impacting stock liquidity.

28. juuli 2026, 23:41 UTC

Correlated Moves
News

Western Digital Corp shares are higher in after-market trading, buoyed by a rise in Seagate Technology Holdings PLC and ongoing AI-driven data storage demand.

28. juuli 2026, 23:41 UTC

Correlated Moves
News

Fuelcell Energy Inc. shares rise in after-market trading, driven by Bloom Energy's stock increase and the launch of new high-temperature fuel cell systems.

28. juuli 2026, 23:41 UTC

Social Media
News

Seagate Technology Holdings reported strong fourth-quarter results, with adjusted EPS of $5.71 and revenue of $3.63 billion, driving shares higher in after-market hours.

28. juuli 2026, 23:41 UTC

News

OPKO Health reported a narrowed net loss of $8.4 million and raised revenue guidance, but shares are lower in after-market hours following recent gains.

28. juuli 2026, 23:41 UTC

News

Coinbase Global Inc shares are lower in after-market hours following the appointment of Rob Witoff as Chief Technology Officer to enhance AI initiatives.

28. juuli 2026, 23:41 UTC

News

Netflix shares are higher in after-market hours following Canada's plan to eliminate a levy on streaming services, creating a more favorable environment for the industry.

28. juuli 2026, 23:36 UTC

Correlated Moves
News

BX faces increased competition after BlackRock's $220 billion deal.

28. juuli 2026, 23:36 UTC

News

Zillow Group faces a potential securities fraud class action lawsuit, leading shares to trade lower in after-market hours amid investor concerns.

Võrdlus sarnastega

Hinnamuutus

Heron Therapeutics Inc Prognoos

Hinnasiht

By TipRanks

316.67% tõus

12 kuu keskmine prognoos

Keskmine 2 USD  316.67%

Kõrge 2 USD

Madal 2 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Heron Therapeutics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

1

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

30 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
help-icon Live chat